MIRA Pharmaceuticals | 3:首次持股声明-董事 Whalen Matthew Pratt
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 144:拟议出售证券
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 10-Q:2024财年三季报
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 424B5:募资说明书
MIRA Pharmaceuticals | S-8:员工福利计划证券登记
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | 144/A:其他
MIRA Pharmaceuticals | 144:拟议出售证券
MIRA Pharmaceuticals | 4:持股变动声明-股东 McNulty Brian Patrick
MIRA Pharmaceuticals | 8-K:重大事件
MIRA Pharmaceuticals | EFFECT:其他
MIRA Pharmaceuticals | 10-Q/A:季度报表(修正版)
MIRA Pharmaceuticals | CORRESP:信函
MIRA Pharmaceuticals | UPLOAD:其他
MIRA Pharmaceuticals | 10-Q:2024财年二季报
暂无数据
暂无数据